triazoles has been researched along with Leukemia, Myeloid, Acute in 238 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.42) | 18.7374 |
| 1990's | 1 (0.42) | 18.2507 |
| 2000's | 34 (14.29) | 29.6817 |
| 2010's | 162 (68.07) | 24.3611 |
| 2020's | 40 (16.81) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, S; Si, Y; Wang, J; Wang, Y; Yin, X; Yu, L | 1 |
| Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS | 1 |
| DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F | 1 |
| Ben-Ami, R; Brüggemann, RJ; Busca, A; Cornely, OA; de Jonge, N; Lewis, R; Piechotta, V; Ráčil, Z; Sinkó, J; Skoetz, N; Stemler, J | 1 |
| Alexander, BD; Engemann, A; Johnson, MD; Rizzieri, D; Sarpong, E; Strand, AM; Wong, JR; Wu, Y | 1 |
| Biemond, BJ; Boersma, RS; Chalandon, Y; de Weerdt, O; Deeren, D; Efthymiou, A; Fehr, M; Graux, C; Gregor, M; Heim, D; Janssen, JJWM; Jongen-Lavrencic, M; Klein, SK; Legdeur, MCJC; Löwenberg, B; Manz, M; Ossenkoppele, GJ; Pabst, T; Sinnige, HAM; Spertini, O; Stüssi, G; Tick, LW; van der Poel, MWM; van Norden, Y; van Obbergh, F; van Sluis, G; Westerweel, PE | 1 |
| Bekker-Jensen, DB; Blume-Jensen, P; Eguchi, A; Emdal, KB; Itzykson, R; Kazi, JU; Masson, K; Nilsson, H; Olsen, JV; Palacio-Escat, N; Puissant, A; Rönnstrand, L; Saez-Rodriguez, J; Wigerup, C | 1 |
| Fujita, N; Kameoka, Y; Kitadate, A; Kobayashi, T; Miura, M; Nara, M; Sato, H; Takahashi, N; Yamashita, T; Yoshioka, T | 1 |
| Huang, L; Liao, X; Lin, D; Shang, D; Wang, X; Wu, L; Yang, L; Yu, L; Zeng, Y; Zhang, J; Zhang, Y; Zi, J | 1 |
| Menna, P; Minotti, G; Salvatorelli, E | 1 |
| Guarana, M; Nucci, M | 1 |
| Ades, L; Attalah, H; Chermat, F; Cluzeau, T; Cross, M; Descot, A; Fenaux, P; Giagounidis, A; Gloaguen, S; Götze, KS; Jentzsch, M; Kayser, S; Kubasch, AS; Medyouf, H; Metzeler, KH; Peterlin, P; Platzbecker, U; Puttrich, M; Schipp, D; Schneider, M; Sebert, M; Sockel, K; Teipel, R; Tirado-Gonzalez, I; van de Loosdrecht, A; Weigert, A | 1 |
| Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K | 1 |
| Bellanger, AP; Berceanu, A; Daguindau, E; Desbrosses, Y; Millon, L; Rocchi, S; Scherer, E | 1 |
| Chavez, J; Cubitt, CL; Dawson, JL; Komrokji, R; Lancet, JE; List, AF; Padron, E; Sallman, DA; Shah, BD; Sullivan, DM; Sweet, K; Turner, JG; Zhou, J | 1 |
| Abboud, CN; Abboud, R; Chendamarai, E; DiPersio, JF; Ghobadi, A; Pusic, I; Rettig, MP; Riedell, PA; Schroeder, MA; Stockerl-Goldstein, K; Trinkaus, KM; Uy, GL; Vij, R; Westervelt, P | 1 |
| Baron, R; Berthou, C; Couturier, MA; Guillerm, G; Ianotto, JC; Le Bars, H; Le Clech, L; Narbonne, V; Nevez, G; Payan, C; Quinio, D; Saliou, P; Uguen, M | 1 |
| Moncada, D; Ramírez, I | 1 |
| Athans, V; Brizendine, KD; Cober, E; Copley, MS; Siebenaller, C; Waldron, M; Welch, SC | 1 |
| Bivins, CA; Borthakur, G; Bose, P; Daver, N; Estrov, Z; Huang, X; Kadia, TM; Kantarjian, HM; Konopleva, M; Kontoyiannis, DP; Marx, KR; Masarova, L; McCue, D; Naqvi, K; Pemmaraju, N; Pierce, SA; Qiao, W; Rausch, CR; Ravandi, F; Takahashi, K; Wiederhold, NP; Wurster, S; Yilmaz, M | 1 |
| Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D | 1 |
| Artz, AS; Bishop, M; Cooperrider, JH; Fulton, N; Kosuri, S; Larson, RA; Liu, H; Stock, W | 1 |
| Cornely, OA; Koehler, P; Maurer, C; Müller, C; Stemler, J | 1 |
| Amberg, S; Bokemeyer, C; Christine Wilke, A; Chromik, J; Deppermann, U; Fiedler, W; Ganser, A; Heuser, M; Janning, M; Kebenko, M; Kranich, AL; Modemann, F; Schlipfenbacher, V; Serve, H; Theile, S; Thol, F | 1 |
| Chen, TT; Cheng, FM; Lin, CC; Tien, JZ; Yeh, SP | 1 |
| Usayaporn, S; Vanichanan, J; Weeraphon, B | 1 |
| Deng, M; Guo, C; Li, Z; Lin, Y; Pu, X; Qiu, Y; Shi, Y; Song, H; Xu, B; Ye, J; Zeng, H; Zha, J; Zhao, H; Zhou, Y | 1 |
| Beigelman-Aubry, C; Bochud, PY; Burger, R; Coste, AT; Krueger, T; Lamoth, F; Letovanec, I; Lovis, A; Spertini, O; Stavropoulou, E | 1 |
| Abdel-Wahab, O; Alvarez, K; Chung, SS; Gönen, M; Klimek, VM; Mi, X; Paffenholz, SV; Park, JH; Penson, AV; Rampal, RK; Sen, F; Sigler, A; Stein, EM; Tallman, MS; Taylor, J | 1 |
| Brachet, M; Dakik, H; El Dor, M; Gouilleux, F; Haudebourg, E; Mazurier, F; Polomski, M; Prié, G; Zibara, K | 1 |
| Diana, A; Isabel Cristina, RS; Karen, A | 1 |
| Abdul-Hamil, NA; Cherchione, C; Martinelli, G; Nagarajan, C; Wong, GC | 1 |
| Chen, Q; Deng, M; Lai, Q; Shi, P; Wu, H; Xu, B; Zha, J; Zhao, H | 1 |
| Azar, MM; Pischel, L; Ringer, M | 1 |
| Arikan, K; Aytac, S; Büyükcam, A; Cengiz, AB; Cetin, M; Cetinkaya, FD; Ceyhan, M; Kara, A; Ozsurekci, Y | 1 |
| Chen, Y; Deng, H; Du, W; Gao, H; He, Q; Lan, T; Li, T; Liu, Y; Meng, X; Rao, Y; Shao, X; Sun, X; Tao, X; Tong, Y; Wang, L; Wang, W; Wu, Y; Xu, A; Yang, B; Ying, M; Zhong, T | 1 |
| Del Principe, MI; Marchesi, F; Menna, P; Minotti, G; Pagano, L; Perrone, S; Salvatorelli, E | 1 |
| Acuña-Cruz, E; Barragán, E; Bergua, JM; Boluda, B; Cano-Ferri, I; Martín-Herreros, B; Martínez Sánchez, MP; Martínez-Cuadrón, D; Martínez-López, J; Megías-Vericat, JE; Montesinos, P; Rodríguez-Veiga, R; Sanz, M; Sargas, C; Sempere, A; Serrano, A; Suárez-Varela, S; Torrent, A; Torres-Miñana, L; Vives, S | 1 |
| Cheng, T; Guo, D; Ma, X; Ren, Q; Wang, N; Yin, J; You, N; Zhang, P; Zhao, Y; Zhu, W | 1 |
| Choi, EJ; Choi, SH; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Park, HS; Yang, E | 1 |
| Aleissa, MM; Alshehri, BS; Gonzalez-Bocco, IH; Leblebjian, H; Luskin, MR; Marty, FM; McDonnell, AM | 1 |
| Andreeff, M; Baz, R; Carlson, R; Gabrail, N; Garzon, R; Gutierrez, M; Kashyap, T; Kauffman, M; Klebanov, B; Mau-Sorensen, PM; Rashal, T; Saint-Martin, JR; Savoie, L; Savona, M; Shacham, S; Stone, R; Unger, TJ; Wagner-Johnston, N; Yee, K | 1 |
| Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT | 1 |
| Aitken, SL; Granwehr, B; Heo, ST; Kontoyiannis, DP; Tverdek, FP | 1 |
| Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Cesaro, S; De Luca, A; Delia, M; Dragonetti, G; Fanci, R; Guglielmi, G; Lessi, F; Martino, G; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Tumbarello, M; Verga, L | 1 |
| Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
| Abraham, A; Abraham, OC; Abubacker, FN; George, B; Korula, A; Lakshmi, KM; Mathews, V; Michael, JS; Rupali, P; Srivastava, A; Varghese, GM; Viswabandya, A | 1 |
| Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
| Fallon, MJ; Liebenstein, TK; Widmer, KM | 1 |
| Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J | 1 |
| Aoun, M; Cornely, OA; Geddes, M; Grigg, A; Haider, S; Hammond, SP; Heinz, WJ; Hepler, DA; Kartsonis, NA; Maertens, J; Meyer, RG; Mullane, KM; Ostermann, H; Raad, I; Robertson, MN; Schanz, U; Ullmann, AJ; Van Iersel, MLPS; Waskin, H; Zimmerli, S | 1 |
| Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M | 1 |
| Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH | 1 |
| Cangemi, G; Castagnola, E; Dufour, C; Mesini, A; Palmisani, E | 1 |
| Bailleux, C; Gari-Toussaint, M; Gastaud, L; Hasseine, L; Martiano, D; Simon, L | 1 |
| Baum, A; Beck, J; Engelhardt, H; Gerlach, D; Gerstberger, T; Hofmann, MH; Kaya, O; Kraut, N; Popow, J; Savarese, F; Scharn, D; Schweifer, N; Tontsch-Grunt, U; Zuber, J | 1 |
| Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
| Tollkuci, E | 1 |
| McKinnon, M; Reimer, EK; Stock, W; Wassermann, T | 1 |
| Abgueguen, P; Danneels, P; Dib, M; Dubée, V; Klosek, M; Le Govic, Y; Mahieu, R; Rabier, V | 1 |
| Ahmad, HM; Belaghzal, H; Bushweller, JH; Castilla, LH; Dekker, J; Hegde, M; Illendula, A; Muller-Tidow, C; O'Hagan, K; Ou, J; Pulikkan, JA; Wolfe, SA; Yu, J; Zhu, LJ | 1 |
| Blank, A; Carls, A; Egerer, G; Geist, MJP; Heinz, WJ; Hohmann, N; Mikus, G | 1 |
| Chng, WJ; Lu, X; Tan, TZ; Zhou, J; Zhou, Y | 1 |
| Della Pepa, R; Giordano, C; Grimaldi, F; Mortaruolo, C; Pane, F; Picardi, M; Pugliese, N; Raimondo, M; Salvatore, P; Sirignano, C; Trastulli, F; Zacheo, I | 1 |
| Akalın, H; Demirdöğen, E; Ener, B; Ersal, T; Kazak, E; Mıstık, R; Özkalemkaş, F; Özkocaman, V; Seyhan, S; Ursavaş, A | 1 |
| Brunetti, L; Buckley, DL; Falini, B; Gionfriddo, I; Goodell, MA; Gundry, MC; Guzman, AG; Huang, YH; Kornblau, SM; Lin, CY; Martelli, MP; Mezzasoma, F; Milano, F; Nabet, B; Ramabadran, R; Sorcini, D; Sportoletti, P | 1 |
| Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J | 1 |
| Marini, BL; Perissinotti, AJ | 1 |
| Edwards, H; Ge, Y; Lin, H; Liu, S; Luedtke, DA; Su, Y; Taub, JW; Wang, Y | 1 |
| Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Rossi, G; Venditti, A | 1 |
| Baccelli, I; Bertomeu, T; Blouin-Chagnon, V; Boivin, I; Bordeleau, ME; Boucher, G; Corneau, S; Coulombe-Huntington, J; Frechette, M; Gareau, Y; Gingras, S; Girard, S; Hébert, J; Kanshin, E; Krosl, J; Lavallée, VP; Lehnertz, B; Lemieux, S; Leveillé, K; MacRae, T; Marinier, A; Mayotte, N; Roux, PP; Sauvageau, G; Spinella, JF; St-Denis, C; Thibault, P; Thiollier, C; Tyers, M | 1 |
| Estey, EH; Percival, MM | 1 |
| Dama, P; Fulton, N; Kline, J; Liu, H; Tang, M | 1 |
| Campos, VF; Cruz, LR; Danilow, MZ; dos Santos, VM; Paixão, GT; Ribeiro, EF | 1 |
| Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC | 1 |
| Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
| Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z | 1 |
| Barrett, DM; Gerber, JS; Larru, B | 1 |
| Andreeff, M; Burks, JK; Coombes, KR; Davis, RE; Dilip, A; Duvvuri, S; Kantarjian, H; Kauffman, M; Kojima, K; Kornblau, SM; Qiu, YH; Ruvolo, V; Shacham, S; Wang, Z; Zhang, M; Zhang, N | 1 |
| Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L | 1 |
| Butler, J; Curley, C; Durrant, S; Kennedy, GA; Morris, KL; Subramonpillai, E | 1 |
| Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
| Cornely, OA; Glossmann, J; Hallek, M; Heimann, SM; Kochanek, M; Kreuzer, KA; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Guinea de Castro, JM; Moreno de Gusmão, B; Oiartzabal, I; Perez-Persona, E | 1 |
| Alkhaeir, S; Callens, C; Damaj, G; Dussiot, M; Gorin, NC; Hermine, O; Isnard, F; Marolleau, JP; Monteiro, RC; Moura, IC; Paubelle, E; Rubio, MT; Suarez, F; Zylbersztejn, F | 1 |
| Bertz, H; Drognitz, K; Lübbert, M | 1 |
| Candoni, A; Cojutti, P; Fanin, R; Franceschi, L; Pea, F; Simeone, E | 1 |
| Allione, B; Audisio, E; Aydin, S; Barbui, AM; Busca, A; D'Ardia, S; De Rosa, FG; Dellacasa, CM; Falda, M; Frairia, C; Manetta, S; Marmont, F; Pecoraro, C; Vitolo, U | 1 |
| Dony, A; Ducastelle, S; Ferry, T; Perpoint, T | 1 |
| Chang, CS; Hsiao, HH; Hsu, JF; Lin, SF; Liu, TC; Liu, YC; Lu, PL; Wu, CH | 1 |
| Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE | 2 |
| Gagne, LS; Gilmore, ET; Hammond, SP; Joyce, AC; Marty, FM; Peixoto, D; Soiffer, RJ | 1 |
| Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC | 1 |
| Tohyama, K | 1 |
| Conner, JR; Jacobson, FL; Juan, YH; Khandelwal, A; Lin, YC; Saboo, SS | 1 |
| Valent, P; Zuber, J | 1 |
| Merkel, DG; Nagler, A | 1 |
| Billaud, E; Borget, I; Boussion, H; Burlacu, R; Chachaty, E; de Botton, S; Desplanques, PY; Gachot, B; Micol, JB; Netzer, F; Poinsignon, V; Wyplosz, B | 1 |
| Bradner, JE; Chen, C; Dickins, RA; Kitzing, T; Kogan, S; LeBeau, MM; Liu, Y; Lowe, SW; Rappaport, AR; Schultz, N; Shannon, KM; Shroff, AS; Stock, W; Vakoc, CR; Zhao, Z; Zuber, J | 1 |
| Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J | 1 |
| Aversa, F; Ballanti, S; Busca, A; Caira, M; Candoni, A; Castagnola, C; Cattaneo, C; Fanci, R; Lessi, F; Martino, B; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Salutari, P; Tumbarello, M; Verga, L | 1 |
| Choudhury, S; Marte, RL | 1 |
| Bhalla, KN; Bradner, JE; Devaraj, SG; Fiskus, W; Iyer, S; Leveque, C; Portier, BP; Qi, J; Shah, B; Sharma, S | 1 |
| Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U | 1 |
| Green, MR; Hummert, SE | 1 |
| Böhme, A; Cornely, OA; Schmitt-Hoffmann, A; Ullmann, AJ | 1 |
| Augustin, E; Borowa-Mazgaj, B; Pelikant, I; Sankowska, E; Skwarska, A; Weryszko, A | 1 |
| Bhatnagar, B; Blum, W; Devine, S; Garzon, R; Hofstetter, J; Kauffman, M; Klisovic, R; Marcucci, G; Phelps, MA; Ranganathan, P; Santhanam, R; Shacham, S; Vasu, S; Walker, A; Walsh, K; Yu, X | 1 |
| Bae, SH; Chung, JS; Hyun, MS; Joo, YD; Kim, H; Kim, HG; Kim, IH; Kim, SH; Kim, YS; Kwon, KY; Lee, GW; Lee, HS; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, KT; Ryoo, HM; Sohn, SK | 1 |
| Hochhaus, A; Schnetzke, U; Scholl, S; Schrenk, KG; Stegemann, K; von Lilienfeld-Toal, M | 1 |
| Björkholm, M; Blennow, O; Cederlund, K; Dahlén, T; Kalin, M; Ljungman, P; Nordlander, A | 1 |
| Burnett, AK; Hills, R; Lazenby, M; Zabkiewicz, J | 1 |
| Borlenghi, E; Caimi, L; Cattaneo, C; Lamorgese, C; Panzali, A; Passi, A; Petullà, M; Re, A; Rossi, G | 1 |
| Abdul Halim, NA; Tan, BH; Wong, GC | 1 |
| Pagano, L; Tumbarello, M | 1 |
| Borthakur, G; Brown, Y; Cortes, J; Jabbour, E; Kantarjian, H; Konopleva, M; Mattiuzzi, G; Pierce, S; Yilmaz, M | 1 |
| Bhalla, KN; Bradner, JE; Devaraj, SG; Fiskus, W; Iyer, SP; Qi, J; Shah, B; Sharma, S; Sun, B | 1 |
| Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Adamia, S; Berezovskaya, A; Chen, WC; Christie, AL; Conway, AS; Etchin, J; Galinsky, IA; Kauffman, M; Kentsis, A; Klebanov, B; Kung, AL; Landesman, Y; Le, BT; Letai, A; Look, AT; Mansour, MR; Montero, J; Ng, CE; Reed, C; Rodig, SJ; Shacham, S; Stone, RM; Wang, JC | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Anusha, S; Ashwini, N; Bender, A; Fuchs, JE; Garg, M; Kanojia, D; Koeffler, HP; Madan, V; Mohan, CD; Rakesh, KS; Rangappa, KS; Rangappa, S; Swaroop, TR | 1 |
| Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW | 1 |
| Abdel-Wahab, O; Carpenter, C; Dawson, MA; Dawson, SJ; Fong, CY; Ftouni, S; Gilan, O; Giotopoulos, G; Gregory, R; Huntly, BJ; Jeffrey, P; Johnstone, RW; Kouzarides, T; Lam, EY; Lane, SW; Lee, SC; Lugo, D; Morison, J; Papenfuss, AT; Prinjha, RK; Ramsay, RG; Rubin, AF; Sinha, D; Stanley, K; Tyler, D; Yeh, P | 1 |
| Axelsson, E; Boryń, ŁM; Cerny-Reiterer, S; Deswal, S; Dow, LE; Gianni, D; Hoffmann, T; Jude, J; Kraut, N; Muerdter, F; Muhar, M; Neumann, T; Pearson, M; Peter, B; Rathert, P; Roe, JS; Roth, M; Schweifer, N; Stark, A; Tontsch-Grunt, U; Vakoc, CR; Valent, P; Zuber, J | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Calia, C; Capolongo, C; Dalfino, L; Delia, M; Giannelli, G; Ianora, AA; Monno, R; Pastore, D; Specchia, G; Tortorano, A | 1 |
| Arnan, M; Duarte, RF; Pomares, H; Sánchez-Ortega, I; Sureda, A | 1 |
| Bhagwat, AS; Hohmann, AF; Mok, BYL; Roe, JS; Shi, J; Vakoc, CR | 1 |
| Assanelli, A; Barbanti, MC; Bernardi, M; Carrabba, M; Ciceri, F; Corti, C; Forcina, A; Giglio, F; Greco, R; Lupo Stranghellini, MT; Marktel, S; Messina, C; Morelli, M; Oltolini, C; Peccatori, J; Piemontese, S; Scarpellini, P; Vago, L | 1 |
| Baloglu, E; Berezovskaya, A; Conway, AS; Etchin, J; Galinsky, IA; Kauffman, M; Landesman, Y; Look, AT; Senapedis, W; Shacham, S; Stone, RM; Wang, JC | 1 |
| Bhatnagar, B; Blum, W; Dorrance, AM; Garzon, R; Kashyap, T; Kauffman, M; Lai, TH; Landesman, Y; McNeil, B; Meng, X; Ranganathan, P; Sampath, D; Shacham, S; Yu, X | 1 |
| Bernardo, RM; Gurung, A; Jain, D; Malinis, MF | 1 |
| Acharya, P; Bradner, JE; Fischer, MA; Hiebert, SW; Kwak, H; Lis, JT; Liu, Q; Mohan, SR; Savona, MR; Sheng, Q; Stengel, KR; Strickland, SA; Venters, BJ; Zhao, Y; Zhou, MM; Zhou, X | 1 |
| Alzghari, SK; Cable, CT; Herrington, JD; Seago, SE | 1 |
| Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A | 1 |
| Corallo, C; Coutsouvelis, J; Maleki, S; Singh, J | 1 |
| Coignard-Biehler, H; Jullien, V; Lanternier, F; Lortholary, O; Pilmis, B; Rouzaud, C | 1 |
| Burgess, MJ; Crescencio, JC; Kothari, A; Shalin, SC | 1 |
| Agarwal, SK; DiNardo, CD; Dunbar, M; Humerickhouse, RA; Kantarjian, HM; Konopleva, MY; Menon, RM; Potluri, J; Salem, AH; Wong, SL | 1 |
| McCarthy, MW; Walsh, TJ | 1 |
| Benedetti, E; Focosi, D; Galimberti, S; Kast, RE; Metelli, MR; Papineschi, F; Petrini, M | 1 |
| Karthaus, M | 1 |
| Codl, D; Laznickova, T; Malaskova, L; Masova, I; Nyc, O; Sedlacek, P; Stary, J; Vavra, V | 1 |
| Kishel, JJ; Sivik, J | 1 |
| Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB | 1 |
| AbuTarif, M; Angulo, D; Cornely, OA; Krishna, G; Martinho, M; Xuan, F | 1 |
| Doorduijn, JK; el Barzouhi, A; Lugtenburg, PJ; Polinder, S; Rijnders, BJ; Slobbe, L; Steyerberg, EW | 1 |
| Fanci, R | 1 |
| Debelenko, L; Fothergill, AW; Hayden, RT; Rinaldi, MG; Romanelli, AM; Rubnitz, JE; Shenep, JL; Srinivasan, A; Sutton, DA; Thompson, EH; Wickes, BL | 1 |
| Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A | 1 |
| Hansel-Esteller, S; Selvy, N; Villiet, M | 1 |
| Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
| Olson, EL; Tonelli, AR | 1 |
| Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
| Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T | 1 |
| AbuTarif, MA; Krishna, G; Statkevich, P | 1 |
| Cornely, OA; Rüping, MJ; Vehreschild, JJ | 1 |
| Collins, CD; DePestel, DD; Mackler, ER; Nemerovski, CW; Stevenson, JG; Welch, KS | 1 |
| Chalandon, Y; Garbino, J; Lamoth, F; Lebeau, O; Passweg, J; Robert, J; Van Delden, C | 1 |
| Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G | 1 |
| Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K | 1 |
| Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B | 1 |
| Bangard, C; Cornely, OA; Farowski, F; Hallek, M; Kreuzer, KA; Rüping, MJ; Sims, R; Steinbach, A; Stollorz, A; Vehreschild, JJ; Wisplinghoff, H | 1 |
| Greiner, RA; Imhof, A; Meier, Y; O'Sullivan, AK; Papadopoulos, G | 1 |
| Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S | 1 |
| Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K | 1 |
| Andreesen, R; Beier, F; Hildebrandt, GC; Holler, E; Holzmann, T; Kittan, N; Schardt, K | 1 |
| Lazzaro, C | 1 |
| Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG | 1 |
| Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA | 1 |
| Dranitsaris, G; Khoury, H | 1 |
| Coorevits, L; Jeurissen, A; Lagrou, K; Schuermans, C; Surmont, I; van Bergen, M; Verhaegen, J | 1 |
| Egerer, G; Geist, MJ | 1 |
| Andreesen, R; Hahn, J; Holler, E; Reichle, A; Stifel, F | 1 |
| Berger, P; Caillot, D; Dupont, B; Gangneux, JP; Herbrecht, R; Lafuma, A; Michallet, M; Moreau, P; O'Sullivan, AK; Ribaud, P | 1 |
| Bryant, AM; Craig, M; Cumpston, A; Slain, D | 1 |
| Bienvenu, AL; Kraghel, S; Michallet, M; Morisset, S; Nicolini, FE; Nicolle, MC; Picot, S; Sobh, M; Thomas, X; Vanhems, P | 1 |
| Azim, S; Fadoo, Z; Manzoor, NF | 1 |
| Cohen, PR; Riahi, RR | 1 |
| Angoulvant, A; Epaud, R; Le Pointe, HD; Levine, E; Petit, A | 1 |
| Avery, S; Chang, CC; Grigoriadis, G; Morrissey, O; Patil, S; Spencer, A; Walker, P | 1 |
| Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS | 1 |
| Chang, SE; Choi, JH; Kim, MS; Lee, HM; Lee, MW; Moon, KC; Sung, HS; Won, CH | 1 |
| Blatt, K; Bradner, JE; Brown, P; Chicas, A; Herrmann, H; Johns, C; Kogan, SC; Lowe, SW; Magoon, D; Mulloy, JC; Qi, J; Rappaport, AR; Shi, J; Sison, EA; Taylor, MJ; Vakoc, CR; Valent, P; Wang, E; Wunderlich, M; Zuber, J | 1 |
| da Silva, CM; de Carvalho Parahym, AM; de Oliveira, NT; Filho, GA; Leão, MP; Macario, MC; Neves, RP | 1 |
| Balasubramanian, S; Bergeron, L; Bryant, BM; Conery, AR; Mele, DA; Mertz, JA; Sandy, P; Sims, RJ | 1 |
| Bell, JE; Christenson, JC; Hulbert, ML; Imel, EA; Skiles, JL | 1 |
| Arnost, M; Chen, G; Choquette, D; Davies, RJ; Forster, C; Galullo, V; Grey, R; Heidary, DK; Henkel, G; Ma, J; Namchuk, M; Pierce, AC; Stuver-Moody, C; Tian, SK; Xu, J | 1 |
| Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I | 1 |
| Bahcebasi, S; Cetin, M; Deniz, K; Eser, B; Kaynar, L; Kurnaz, F; Ozturk, A; Pala, C; Sivgin, S; Unal, A; Uzer, E | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H | 1 |
| Alimena, G; Breccia, M; Capria, S; Cartoni, C; Foà, R; Frustaci, AM; Gentile, G; Girmenia, C; Latagliata, R; Loglisci, G; Matturro, A; Meloni, G; Micozzi, A; Minotti, C; Trisolini, SM | 1 |
| Arnost, M; Ball, ED; Boucher, D; Chen, G; Choquette, D; Davies, RJ; Forster, C; Grey, R; Heidary, DK; Henkel, G; Huang, G; Ma, J; Namchuk, M; Xu, J; Yao, YM; Zhou, JH | 1 |
| Cornely, OA; Farowski, F; Fuhr, U; Hallek, M; Kohl, V; Kreuzer, KA; Müller, C; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Kato, J; Matsuki, E; Matsumoto, K; Nakaya, A; Okamoto, S; Yamane, A | 1 |
| Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R | 1 |
| Corso, V; Drudi, F; Fantini, M; Imola, M; Mianulli, AM; Pasini, G; Ravaioli, A; Santelmo, C; Veneroni, L | 1 |
| Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
| Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P | 1 |
| Caira, M; Cuenca-Estrella, M; Pagano, L | 1 |
| Bhatt, L; Chang, CJ; Cotter, TG; Dickinson, BC; Gough, DR; Naughton, R; Stanicka, J; Woolley, JF | 1 |
| Aversa, F; Busca, A; Caira, M; Candoni, A; Caramatti, C; Castagnola, C; Cattaneo, C; De Paolis, MR; Delia, M; Di Blasi, R; Di Caprio, L; Fanci, R; Garzia, M; Martino, B; Melillo, L; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Salutari, P; Trecarichi, EM; Tumbarello, M; Verga, L; Vianelli, N | 1 |
| Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Ameye, L; Aoun, M; Bourguignon, AM; Bron, D; Cotton, F; Csergö, M; Hites, M; Jacobs, F; Rasson, C; Vaes, M | 1 |
| Boswell, HS; Bowling, JD; Chan, RJ; Feng, GS; Fukuda, S; Goenka, S; He, Y; Kapur, R; Li, XJ; Liu, Z; Nabinger, SC; Ramdas, B; Richine, B; Sandusky, GE; Yu, M; Zeng, L; Zhang, X; Zhang, ZY | 1 |
| Brisou, P; Darles, C; Gaillard, T; Pons, S; Roméo, E | 1 |
| Menagé, Hdu P; Woolf, RT; Yeghen, T | 1 |
| Blatt, K; Bradner, JE; Cerny-Reiterer, S; Gleixner, KV; Herrmann, H; Horny, HP; Müllauer, L; Shi, J; Sperr, WR; Vakoc, CR; Valent, P; Zuber, J | 1 |
| Allen, PB; Baer, MR; Kleinberg, ME; Koka, R | 1 |
| Klopfenstein, KJ; Powell, D; Rosselet, R; Termuhlen, A | 1 |
| Auner, HW; Dornbusch, HJ; Eibl, M; Linkesch, W; Sill, H; Zinke-Cerwenka, W | 1 |
| Sims-McCallum, RP | 1 |
| Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
| Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Fujisaki, G; Kami, M; Kishi, Y; Kobayashi, K; Mitamura, T; Murashige, N | 1 |
| Chadwick, EG; Guzman-Cottrill, JA; Zheng, X | 1 |
| Correll, TA; Leather, HL; Meyer, CL; Schmalfuss, IM; Wingard, JR | 1 |
| Atta, J; Bialek, R; Herrmann, S; Jacobi, V; Just-Nübling, G; Lambrecht, E; Rickerts, V | 1 |
| Behringer, K; Cornely, OA; Krüger, K; Kurzai, O; Töx, U; Vehreschild, JJ; Wickenhauser, C | 1 |
| Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T | 1 |
| Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ | 1 |
| Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM | 1 |
| Kalnicky, C; Klein, J; Mullane, K; Rodriguez, T; Stiff, P; Toor, AA | 1 |
| Almyroudis, NG; Ball, D; Bambach, BJ; Battiwalla, M; Gupta, S; Kwon-Chung, J; McCarthy, PL; Paplham, P; Proefrock, AD; Segal, BH; Varma, A | 1 |
| Bellmann, R; Weiler, S | 1 |
| van Dissel, JT; van Nieuwkoop, C | 1 |
| Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G | 1 |
| Feldberg, E; Halperin, D; Lahav, J; Warman, M | 1 |
| Boot, B; Danho, C; Huynh, A; Mejdoubi, M | 1 |
| Baldelli, F; Costantini, V; Giovenale, P; Gurdo, G; Lapalorcia, LM; Lignani, A; Pasticci, MB; Pitzurra, L; Terenzi, A; Verzini, F | 1 |
| Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O | 1 |
| Kidd, D; Morris, TC; Ranaghan, EA | 1 |
20 review(s) available for triazoles and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
Topics: Adult; Antifungal Agents; Hematology; Humans; Leukemia, Myeloid, Acute; Mycoses; Quality of Life; Triazoles | 2022 |
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities.
Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles | 2023 |
Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
Topics: Antifungal Agents; Azoles; Bridged Bicyclo Compounds, Heterocyclic; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles | 2023 |
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole | 2020 |
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma.
Topics: Antifungal Agents; Chemoprevention; Drug Interactions; Drugs, Investigational; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Prognosis; Staurosporine; Triazoles | 2020 |
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
Topics: Aged; Antifungal Agents; Biopsy; Conidiobolus; DNA, Fungal; DNA, Ribosomal; Female; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Nitriles; Pyridines; Switzerland; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Zygomycosis | 2020 |
Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.
Topics: Agaricales; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Pneumonia, Necrotizing; Triazoles | 2020 |
Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.
Topics: Aniline Compounds; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Echinocandins; fms-Like Tyrosine Kinase 3; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Mycoses; Protein Kinase Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Recurrence; Staurosporine; Triazoles | 2020 |
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole | 2018 |
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.
Topics: Aminopyridines; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Azacitidine; Cytogenetic Analysis; Decitabine; Enzyme Inhibitors; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunologic Factors; In Situ Hybridization, Fluorescence; Lenalidomide; Leukemia, Myeloid, Acute; Molecular Diagnostic Techniques; Neoplasm, Residual; Nivolumab; para-Aminobenzoates; Protein Kinase Inhibitors; Pyrazines; Pyrrolidines; Recombinant Fusion Proteins; Remission Induction; Transplantation, Homologous; Triazines; Triazoles | 2019 |
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes.
Topics: Administration, Oral; Benzoates; Blood Transfusion; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pyridones; Triazoles | 2014 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Blood; Fatal Outcome; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Lung; Male; Microbial Sensitivity Tests; Microbiological Techniques; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles | 2016 |
Therapeutic Challenges of Hepatic Mucormycosis in Hematologic Malignancy: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Chemotherapy, Adjuvant; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Liver Diseases; Middle Aged; Mucormycosis; Risk Factors; Treatment Failure; Treatment Outcome; Triazoles | 2016 |
Prophylactic Measures During Induction for Acute Myeloid Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Humans; Infections; Leukemia, Myeloid, Acute; Risk Factors; Triazoles | 2017 |
Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Fever; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Medical Oncology; Mycoses; Myelodysplastic Syndromes; Triazoles | 2010 |
Primary invasive oral aspergillosis: an updated literature review.
Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature.
Topics: Aged; Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Female; Geotrichosis; Geotrichum; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2004 |
30 trial(s) available for triazoles and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis.
Topics: Adult; Aged; Humans; Hydrazines; Leukemia, Myeloid, Acute; Meta-Analysis as Topic; Systematic Reviews as Topic; Triazoles | 2021 |
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Topics: Active Transport, Cell Nucleus; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hydrazines; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Triazoles | 2022 |
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial.
Topics: Benzocycloheptenes; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Triazoles | 2023 |
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Hydrazines; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Patient Safety; Survival Rate; Tissue Distribution; Treatment Outcome; Triazoles | 2020 |
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Female; Filgrastim; Humans; Hydrazines; Leukemia, Myeloid, Acute; Male; Mice, Inbred C57BL; Middle Aged; Remission Induction; Treatment Outcome; Triazoles; Young Adult | 2020 |
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Topics: Adult; Aged; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Nitriles; Prospective Studies; Pyridines; Triazoles | 2021 |
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
Topics: Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Transplantation Conditioning; Triazoles | 2020 |
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Progression-Free Survival; Recurrence; Salvage Therapy; Triazoles | 2020 |
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Hydrazines; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Patient Safety; Prognosis; Survival Rate; Triazoles | 2020 |
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Hydrazines; Idarubicin; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Triazoles; Vidarabine | 2021 |
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
Topics: Adult; Blast Crisis; Bone Marrow Cells; Disease-Free Survival; Female; Humans; Hydrazines; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival Rate; Triazoles | 2017 |
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Triazoles; Young Adult | 2017 |
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cytarabine; Drug Resistance, Neoplasm; Female; Galectins; Hepatitis A Virus Cellular Receptor 2; Humans; Hydrazines; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; T-Lymphocyte Subsets; Treatment Failure; Triazoles | 2019 |
A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia.
Topics: Adult; Aged; Benzoates; Consolidation Chemotherapy; Deferasirox; Early Termination of Clinical Trials; Female; Ferritins; Humans; Iatrogenic Disease; Induction Chemotherapy; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult | 2013 |
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory Techniques; Female; Fluconazole; Fungemia; Germany; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles; Young Adult | 2014 |
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Data Collection; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Treatment Outcome; Triazoles; Young Adult | 2014 |
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Nitriles; Patient Safety; Pyridines; Triazoles | 2015 |
Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Benzoates; Deferasirox; Erythrocyte Transfusion; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Triazoles | 2015 |
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Salvage Therapy; Triazoles | 2015 |
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments.
Topics: Administration, Oral; Adult; Antifungal Agents; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP3A; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Sulfonamides; Triazoles | 2017 |
Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Prospective Studies; Single-Blind Method; Triazoles; Young Adult | 2008 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Population; Single-Blind Method; Triazoles; Young Adult | 2010 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
Topics: Aged; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Triazoles | 2012 |
Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Food-Drug Interactions; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Prospective Studies; Spectrophotometry, Ultraviolet; Tacrolimus; Triazoles; Young Adult | 2012 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles | 2007 |
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
188 other study(ies) available for triazoles and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole | 2022 |
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies.
Topics: Adult; Antifungal Agents; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles | 2022 |
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance.
Topics: Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Hydrazines; Leukemia, Myeloid, Acute; Proteome; Proto-Oncogene Proteins c-akt; Triazoles; Tumor Suppressor Protein p53 | 2022 |
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Clarithromycin; Gastrostomy; Humans; Leukemia, Myeloid, Acute; Sulfonamides; Tablets; Triazoles | 2022 |
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization.
Topics: Acute Disease; Administration, Oral; Antifungal Agents; Biological Availability; Child; China; Diet, High-Fat; Humans; Leukemia, Myeloid, Acute; Prospective Studies; Triazoles | 2022 |
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole | 2023 |
Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
Topics: Antifungal Agents; Aspergillus fumigatus; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Treatment Failure; Triazoles | 2019 |
Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Topics: Adult; Aerosols; Air Filters; Air Microbiology; Air Pollution, Indoor; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Combined Modality Therapy; Environmental Exposure; Febrile Neutropenia; Female; Filtration; France; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Hospitals, Teaching; Humans; Incidence; Invasive Fungal Infections; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Retrospective Studies; Spores, Fungal; Triazoles | 2020 |
Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles | 2020 |
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles | 2020 |
Venetoclax plus cytochrome P450 inhibitors without ramp-up strategy led to low risk of tumor lysis syndrome in acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Child; Creatinine; Cytochrome P-450 Enzyme Inhibitors; Drug Administration Schedule; Drug Synergism; Female; Humans; Hyperuricemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Sulfonamides; Triazoles; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Young Adult | 2020 |
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole | 2020 |
Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
Topics: Adult; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Azepines; Biomarkers, Tumor; Cell Proliferation; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Phenanthrenes; Prognosis; Reactive Oxygen Species; RNA Polymerase II; Signal Transduction; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines.
Topics: Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Humans; Leukemia, Myeloid, Acute; Mitochondria; NADPH Oxidases; Oxidative Stress; Pyrimidines; Reactive Oxygen Species; Triazoles; Unfolded Protein Response | 2020 |
Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.
Topics: Apoptosis; Azepines; CCCTC-Binding Factor; Cell Cycle Checkpoints; Cell Line, Tumor; CRISPR-Cas Systems; Gene Expression Regulation, Leukemic; Genetic Loci; Homeodomain Proteins; Humans; Leukemia, Myeloid, Acute; Nucleophosmin; RNA Polymerase II; Transcription, Genetic; Transcriptional Elongation Factors; Triazoles | 2020 |
Diagnosis of oesophageal mucormycosis managed with medical therapy alone.
Topics: Amphotericin B; Antifungal Agents; Cytarabine; Esophageal Diseases; Esophagus; Humans; Idarubicin; Immunocompromised Host; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Rhizopus; Triazoles | 2020 |
Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
Topics: Adolescent; Antifungal Agents; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Tertiary Care Centers; Triazoles | 2021 |
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.
Topics: Antineoplastic Agents; Aurora Kinase A; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Drug Design; Drug Discovery; Gene Expression Regulation, Leukemic; Humans; Ikaros Transcription Factor; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Myeloid Progenitor Cells; Piperazines; Primary Cell Culture; Proteolysis; Pyridines; Pyrimidines; Quinazolines; Signal Transduction; Structure-Activity Relationship; Transcriptome; Triazoles | 2021 |
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 CYP3A; Diarrhea; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Mycoses; Staurosporine; Triazoles | 2021 |
GADD45g acts as a novel tumor suppressor, and its activation suggests new combination regimens for the treatment of AML.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Benzothiazoles; Depsipeptides; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Phenylurea Compounds; THP-1 Cells; Triazoles; Tumor Suppressor Proteins; U937 Cells; Up-Regulation | 2021 |
Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Case-Control Studies; Female; Humans; Incidence; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Seoul; Treatment Outcome; Triazoles | 2021 |
Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib.
Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Antifungal Agents; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prognosis; Pyrazines; Retrospective Studies; Survival Rate; Triazoles; Young Adult | 2021 |
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles | 2017 |
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.
Topics: Administration, Intravenous; Administration, Oral; Algorithms; Antifungal Agents; Cohort Studies; Drug Compounding; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Tablets; Tertiary Care Centers; Treatment Outcome; Triazoles | 2017 |
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Drug Costs; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Monte Carlo Method; Mycoses; Outcome Assessment, Health Care; Triazoles; Young Adult | 2017 |
[Primary antifungal prophylaxis with posaconazole plays a pivotal role during chemotherapy of acute myeloid leukemia].
Topics: Antifungal Agents; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Remission Induction; Retrospective Studies; Triazoles | 2017 |
Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Developing Countries; Female; Humans; India; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Triazoles; Young Adult | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Case-Control Studies; Drug Administration Schedule; Drug Compounding; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Patient Care Planning; Post-Exposure Prophylaxis; Retrospective Studies; Tablets; Triazoles; Young Adult | 2018 |
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles | 2017 |
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles | 2018 |
Hepatic veno-occlusive disease during isavuconazole administration.
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Nitriles; Pyridines; Triazoles; Young Adult | 2018 |
Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Endophthalmitis; Eye; Female; Fusarium; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole | 2018 |
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase 9; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Enhancer Elements, Genetic; Flavonoids; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Piperidines; Proteins; Pyrazines; RNA Polymerase II; RNA-Binding Proteins; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report.
Topics: Adult; Antineoplastic Agents; Cytochrome P-450 CYP3A Inhibitors; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mutation; Nitriles; Protein Kinase Inhibitors; Pyridines; Staurosporine; Triazoles | 2019 |
Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole.
Topics: Aged; Female; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Mineralocorticoid Excess Syndrome, Apparent; Potassium; Triazoles | 2018 |
On the Nose: Disseminated Mucormycosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung Diseases; Male; Mucormycosis; Nose Diseases; Pancytopenia; Treatment Outcome; Triazoles | 2018 |
CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
Topics: Animals; Apoptosis; Azepines; Benzimidazoles; Cell Line, Tumor; Chromatin; Chromosomal Proteins, Non-Histone; Chromosome Inversion; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; DNA; DNA Helicases; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Nuclear Proteins; Oncogene Proteins, Fusion; Polycomb Repressive Complex 1; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-myc; Transcription Factors; Triazoles | 2018 |
Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions.
Topics: Administration, Oral; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Patient Education as Topic; Program Evaluation; Prospective Studies; Retrospective Studies; Suspensions; Treatment Outcome; Triazoles; Young Adult | 2019 |
BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia.
Topics: Apoptosis; Azepines; Carrier Proteins; Cell Cycle Proteins; Cell Line, Tumor; Genes, myc; Genes, Tumor Suppressor; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; MicroRNAs; Nuclear Proteins; Transcription Factors; Triazoles | 2018 |
(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Risk Factors; Triazoles; Vidarabine | 2019 |
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Triazoles; Young Adult | 2018 |
Mutant NPM1 Maintains the Leukemic State through HOX Expression.
Topics: Aged; Animals; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Down-Regulation; Exportin 1 Protein; Female; Gene Expression Regulation, Leukemic; Homeodomain Proteins; Humans; Hydrazines; Karyopherins; Leukemia, Myeloid, Acute; Mice; Mutation; Nuclear Proteins; Nucleophosmin; Proteolysis; Receptors, Cytoplasmic and Nuclear; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Managing liver dysfunction in haematology patients: Switch antifungals, or use the tincture of time?
Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Substitution; Female; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Liver Function Tests; Male; Middle Aged; Mycoses; Retrospective Studies; Time Factors; Triazoles; Young Adult | 2019 |
Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.
Topics: Adult; Aged; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Triazoles | 2018 |
Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management.
Topics: Antifungal Agents; Chemoprevention; Disease Management; Humans; Invasive Fungal Infections; Italy; Leukemia, Myeloid, Acute; Triazoles | 2019 |
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex I; Female; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Mice; Models, Biological; Oxazoles; Oxidative Phosphorylation; Protein Kinase Inhibitors; Receptor, ErbB-2; Triazoles | 2019 |
Mucormycosis in a patient with acute myeloid leukemia successfully treated with liposomal amphotericin B associated with deferasirox and hyperbaric oxygen.
Topics: Adult; Amphotericin B; Antifungal Agents; Benzoates; Bone Marrow; Deferasirox; Drug Therapy, Combination; Female; Humans; Hyperbaric Oxygenation; Immunophenotyping; Karyotyping; Leukemia, Myeloid, Acute; Mucormycosis; Nucleophosmin; Treatment Outcome; Triazoles | 2013 |
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dermatomycoses; Drugs, Chinese Herbal; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Opportunistic Infections; Postoperative Complications; Pyrimidines; Scedosporium; Skin Ulcer; Transplantation Conditioning; Transplantation, Autologous; Triazoles; Voriconazole; Young Adult | 2013 |
Candida krusei arthritis in an adolescent with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2013 |
Prognostic impact and targeting of CRM1 in acute myeloid leukemia.
Topics: Acrylates; Antineoplastic Agents; Biomarkers, Tumor; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Exportin 1 Protein; Female; HL-60 Cells; Humans; Karyopherins; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Prognosis; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Suppressor Protein p53; U937 Cells | 2013 |
Excavated pneumonia: an unusual suspect.
Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Remission Induction; Retrospective Studies; Triazoles; Young Adult | 2014 |
[Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors].
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Azacitidine; Benzoates; Blood Transfusion; Chelation Therapy; Combined Modality Therapy; Deferasirox; Disease Progression; Drug Resistance; Epoetin Alfa; Erythropoietin; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Iron; Iron Chelating Agents; Leukemia, Myeloid, Acute; Male; Recombinant Proteins; Triazoles | 2014 |
Deferasirox and vitamin D improves overall survival in elderly patients with acute myeloid leukemia after demethylating agents failure.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzoates; Case-Control Studies; Cell Differentiation; Deferasirox; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloid Cells; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Triazoles; Vitamin D | 2013 |
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations.
Topics: Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Proton Pump Inhibitors; Retrospective Studies; Triazoles | 2013 |
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2014 |
Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Female; Fusariosis; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Fungal; Fatal Outcome; Female; Fever; Fusariosis; Fusarium; Humans; Idarubicin; Leukemia, Myeloid, Acute; Triazoles; Young Adult | 2014 |
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Isavuconazole treatment of a patient with disseminated mucormycosis.
Topics: Antifungal Agents; Brain; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lung; Male; Middle Aged; Mucormycosis; Nitriles; Pyridines; Rhizomucor; Skin; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles | 2014 |
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2014 |
Reverse halo sign in pulmonary mucormyosis.
Topics: Amphotericin B; Antifungal Agents; Biopsy, Fine-Needle; Humans; Image-Guided Biopsy; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Multiple Pulmonary Nodules; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2014 |
BRD4: a BET(ter) target for the treatment of AML?
Topics: Antineoplastic Agents; Azepines; Female; Humans; Leukemia, Myeloid, Acute; Male; Molecular Targeted Therapy; Neoplastic Stem Cells; Nuclear Proteins; Transcription Factors; Triazoles | 2014 |
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
Topics: Aged; Antifungal Agents; Aspergillus; Echinocandins; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Triazoles; Voriconazole | 2014 |
Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Triazoles; Young Adult | 2014 |
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
Topics: Animals; Azepines; Cell Differentiation; Cell Transformation, Neoplastic; Chromosome Deletion; Chromosomes, Human, Pair 7; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Resistance, Neoplasm; Gene Dosage; Haploinsufficiency; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Myeloid-Lymphoid Leukemia Protein; RNA Interference; RNA, Small Interfering; Triazoles; Tumor Suppressor Proteins | 2014 |
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles | 2014 |
Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
Topics: Aged; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Malassezia; Male; Mycoses; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superinfection; Triazoles | 2014 |
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Proteins; Drug Resistance, Neoplasm; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mice; Nuclear Proteins; Pyridazines; Signal Transduction; Transcription Factors; Triazoles; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles | 2014 |
Therapeutic Drug Monitoring and Dose Adjustment of Posaconazole Oral Suspension in Adults With Acute Myeloid Leukemia.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Triazoles | 2015 |
The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Dose-Response Relationship, Drug; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Mutation; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; STAT5 Transcription Factor; Time Factors; Transfection; Triazoles; U937 Cells | 2015 |
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA Methylation; DNA Modification Methylases; Exportin 1 Protein; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Hydrazines; Karyopherins; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Cells, Cultured; Up-Regulation | 2015 |
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Randomized Controlled Trials as Topic; Retrospective Studies; Suspensions; Triazoles; Young Adult | 2015 |
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Fluconazole; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Remission Induction; Retrospective Studies; Survival Analysis; Triazoles | 2016 |
The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Dose-Response Relationship, Drug; Female; HL-60 Cells; HSP90 Heat-Shock Proteins; Humans; Leukemia, Myeloid, Acute; Male; Proto-Oncogene Proteins c-akt; Triazoles | 2015 |
Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Fungemia; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Serum; Triazoles; Young Adult | 2015 |
Phthalimide-Conjugated Ligands Promote Selective Protein Destabilization.
Topics: Adaptor Proteins, Signal Transducing; Azepines; Cell Cycle Proteins; Humans; Leukemia, Myeloid, Acute; Ligands; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Proteasome Endopeptidase Complex; Transcription Factors; Triazoles; Ubiquitin-Protein Ligases | 2015 |
Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
Reply to Wong et al.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Cycle Proteins; Humans; Leukemia, Myeloid, Acute; Mice; Nuclear Proteins; RNA-Binding Proteins; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles | 2015 |
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice.
Topics: Animals; Exportin 1 Protein; Humans; Hydrazines; Immunosuppression Therapy; Karyopherins; Leukemia, Myeloid, Acute; Mice; Neoplastic Stem Cells; Receptors, Cytoplasmic and Nuclear; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Remission Induction; Republic of Korea; Retrospective Studies; Time Factors; Triazoles | 2015 |
Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; G1 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Isoxazoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Triazoles; Tubulin | 2015 |
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles | 2016 |
BET inhibitor resistance emerges from leukaemia stem cells.
Topics: Animals; Azepines; Benzodiazepines; beta Catenin; Cell Cycle Proteins; Cell Line, Tumor; Cells, Cultured; Chromatin; Clone Cells; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, myc; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Targeted Therapy; Neoplastic Stem Cells; Nuclear Proteins; Transcription Factors; Transcription, Genetic; Triazoles; Wnt Signaling Pathway | 2015 |
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.
Topics: Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Chromatin; Drug Resistance, Neoplasm; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Leukemia, Myeloid, Acute; Male; Mice; Nuclear Proteins; Transcription Factors; Transcription, Genetic; Triazoles; Wnt Signaling Pathway | 2015 |
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic-Myeloproliferative Diseases; Neutropenia; Numbers Needed To Treat; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triazoles | 2016 |
BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements.
Topics: Animals; Azepines; Blast Crisis; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Genome; Leukemia, Myeloid, Acute; Mediator Complex; Mice; Nuclear Proteins; Protein Subunits; Regulatory Sequences, Nucleic Acid; RNA Polymerase II; Transcription Factors; Transcription, Genetic; Triazoles | 2016 |
Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Risk; Sirolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult | 2016 |
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Blast Crisis; Carcinogenesis; Exportin 1 Protein; Hematopoietic Stem Cells; Heterografts; Humans; Hydrazines; Karyopherins; Leukemia, Myeloid, Acute; Mice; Receptors, Cytoplasmic and Nuclear; Triazoles | 2017 |
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Proto-Oncogene Proteins c-myc; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Topoisomerase II Inhibitors; Triazoles | 2016 |
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML.
Topics: Antineoplastic Agents; Azepines; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Clustered Regularly Interspaced Short Palindromic Repeats; DNA-Directed RNA Polymerases; Drug Resistance, Neoplasm; Enhancer Elements, Genetic; Gene Expression Regulation, Leukemic; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myeloid, Acute; MicroRNAs; Multigene Family; Myeloid Cell Leukemia Sequence 1 Protein; Promoter Regions, Genetic; Protein Isoforms; Proteins; Proto-Oncogene Proteins c-kit; Transcription, Genetic; Translocation, Genetic; Triazoles | 2016 |
Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
Topics: Cytarabine; Drug Interactions; Erythema; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Triazoles; Young Adult | 2017 |
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult | 2016 |
Failure to achieve therapeutic levels with high-dose posaconazole tablets potentially due to enhanced clearance.
Topics: Antifungal Agents; Drug Monitoring; Humans; Leukemia, Myeloid, Acute; Male; Metabolic Clearance Rate; Middle Aged; Tablets; Triazoles | 2018 |
Acute reversible pancreatitis induced by posaconazole.
Topics: Acute Disease; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Lipase; Mycoses; Pancreatitis; Triazoles | 2017 |
Skin lesion in a patient with acute myeloid leukemia.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Biopsy; Debridement; Dermatomycoses; Febrile Neutropenia; Forearm; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Polymerase Chain Reaction; Rhizopus; RNA, Fungal; Triazoles | 2017 |
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure.
Topics: Cell Division; Chemokine CXCL12; Dipeptidyl-Peptidase IV Inhibitors; Female; Graft Rejection; Hematopoietic Stem Cells; Humans; Hydrolysis; Leukemia, Myeloid, Acute; Middle Aged; Protease Inhibitors; Pyrazines; Sitagliptin Phosphate; Triazoles | 2009 |
Treatment of aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles | 2008 |
Successful therapy with ABLC, surgery and posaconazole for Rhizopus microsporus var. rhizopodiformis liver eumycetoma in a child with acute leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Infant; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male; Mycetoma; Rhizopus; Triazoles | 2009 |
Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Patient Compliance; Patient Education as Topic; Triazoles | 2008 |
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Therapy; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cutaneous infection caused by Macrophomina phaseolina in a child with acute myeloid leukemia.
Topics: Antifungal Agents; Ascomycota; Child; Dermatomycoses; DNA, Fungal; DNA, Ribosomal Spacer; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Molecular Sequence Data; Sequence Analysis, DNA; Skin; Triazoles | 2009 |
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
[Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Service, Hospital; Postoperative Complications; Premedication; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Triazoles | 2010 |
A 19-year-old man with progressive lung infiltrates.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bronchoscopy; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult; Zygomycosis | 2009 |
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2010 |
Drug costs and utilization after implementation of a posaconazole prophylaxis protocol in adults with acute myelogenous leukemia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Drug Costs; Drug Utilization; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pharmacy Service, Hospital; Retrospective Studies; Triazoles | 2010 |
Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mucormycosis; Rhizopus; Salvage Therapy; Transplantation, Homologous; Treatment Outcome; Triazoles | 2010 |
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2010 |
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Germany; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Polyenes; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2010 |
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Markov Chains; Models, Theoretical; Mycoses; Myelodysplastic Syndromes; Neutropenia; Risk; Switzerland; Treatment Outcome; Triazoles | 2010 |
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2011 |
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
Topics: Abscess; Antifungal Agents; Caspofungin; Echinocandins; Female; Forearm; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles | 2011 |
Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Triazoles | 2011 |
Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Graft vs Host Disease; Hematology; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Triazoles; Young Adult | 2011 |
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
Topics: Acute Disease; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Female; France; Fungi; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; National Health Programs; Triazoles | 2011 |
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Triazoles | 2011 |
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Case-Control Studies; Chemoprevention; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Risk Factors; Triazoles | 2011 |
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Voriconazole-associated phototoxicity.
Topics: Antifungal Agents; Bone Marrow Transplantation; Dermatitis, Phototoxic; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Sunlight; Triazoles; Voriconazole | 2011 |
Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Lung Abscess; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole | 2011 |
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection.
Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mucormycosis; Pyrimidines; Radiography; Remission Induction; Transplantation, Homologous; Triazoles; Voriconazole | 2012 |
A case of pseudomembranous colitis after voriconazole therapy.
Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fusariosis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
Topics: Acetylation; Animals; Azepines; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromatin; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, myc; Histones; Humans; Leukemia, Myeloid, Acute; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Nuclear Proteins; RNA Interference; RNA, Small Interfering; Transcription Factors; Triazoles | 2011 |
Invasive infection in an acute myeloblastic leukemia patient due to triazole-resistant Candida tropicalis.
Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Shock, Septic; Triazoles | 2011 |
Targeting MYC dependence in cancer by inhibiting BET bromodomains.
Topics: Animals; Apoptosis; Azepines; Blotting, Western; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Polymerase Chain Reaction; Protein Structure, Tertiary; RNA, Small Interfering; Transcription Factors; Triazoles | 2011 |
Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Fluorides; Fusariosis; Humans; Leukemia, Myeloid, Acute; Male; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; fms-Like Tyrosine Kinase 3; Humans; Hydrogen Bonding; Injections, Intravenous; Leukemia, Myeloid, Acute; Macaca fascicularis; Mice; Mice, Inbred BALB C; Models, Molecular; Morpholines; Protein Binding; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triazoles | 2011 |
Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT).
Topics: Adolescent; Adult; Benzoates; Deferasirox; Female; Hematopoietic Stem Cell Transplantation; Humans; Iron Chelating Agents; Iron Overload; Kidney; Leukemia; Leukemia, Myeloid, Acute; Liver; Male; Middle Aged; Phlebotomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous; Triazoles; Young Adult | 2012 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult | 2012 |
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Hospitalization; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Survival Analysis; Treatment Outcome; Triazoles; Young Adult | 2012 |
VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred BALB C; Morpholines; Neoplasm Transplantation; Proto-Oncogene Proteins c-kit; Serum; Triazoles; Tumor Cells, Cultured | 2012 |
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Models, Biological; Mycoses; Myelodysplastic Syndromes; Suspensions; Triazoles; Young Adult | 2012 |
[Marked improvement of anemia during treatment with deferasirox in patients with primary myelofibrosis and acute myeloid leukemia with myelodysplasia-related changes].
Topics: Aged; Aged, 80 and over; Benzoates; Deferasirox; Erythrocyte Transfusion; Female; Hematopoiesis; Humans; Iron Chelating Agents; Iron Overload; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Primary Myelofibrosis; Treatment Outcome; Triazoles | 2012 |
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2012 |
Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Colectomy; Emergencies; Enterocolitis, Necrotizing; Female; Humans; Ileostomy; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
The management of febrile neutropenia in the posaconazole era: a new challenge?
Topics: Antifungal Agents; Antineoplastic Agents; Fever; Fungi; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mannans; Mycoses; Neutropenia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2012 |
H2O2 production downstream of FLT3 is mediated by p22phox in the endoplasmic reticulum and is required for STAT5 signalling.
Topics: Benzoxazoles; Cell Line, Tumor; Endoplasmic Reticulum; Fluorescent Dyes; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hydrogen Peroxide; Imidazoles; Leukemia, Myeloid, Acute; Mitochondria; Mutation; NADPH Oxidases; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-pim-1; Pyrroles; RNA, Small Interfering; Signal Transduction; STAT5 Transcription Factor; Staurosporine; Triazoles | 2012 |
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Topics: Animals; Base Sequence; bcl-X Protein; Blotting, Western; Bone Marrow Transplantation; Cell Proliferation; Chromatin Immunoprecipitation; Fluorescent Antibody Technique; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cells; Humans; Immunoprecipitation; Indoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Mutation; Phosphorylation; Precursor Cells, B-Lymphoid; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT5 Transcription Factor; Survival Rate; Tandem Repeat Sequences; Triazoles | 2013 |
[Disseminated infection due to Geotrichum capitatum].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Geotrichosis; Geotrichum; Granuloma; Hepatitis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Male; Neutropenia; Opportunistic Infections; Sepsis; Triazoles | 2012 |
A rash in a patient with neutropenia.
Topics: Aged; Antifungal Agents; Dermatomycoses; Fever; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Triazoles | 2012 |
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Cell Cycle Proteins; Cell Proliferation; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Male; Membrane Glycoproteins; Middle Aged; Molecular Targeted Therapy; Neoplastic Stem Cells; Nuclear Proteins; RNA, Messenger; Transcription Factors; Triazoles; Tumor Cells, Cultured; U937 Cells; Young Adult | 2012 |
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole | 2013 |
Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Mycetoma; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2003 |
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Myeloablative Agonists; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation Conditioning; Triazoles; Voriconazole | 2004 |
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Topics: Amphotericin B; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Rhizopus; Triazoles; Zygomycosis | 2005 |
Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Liposomes; Middle Aged; Mucormycosis; Rhizomucor; Treatment Outcome; Triazoles | 2006 |
Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Esophagitis; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous; Triazoles | 2006 |
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Torsades de pointes associated with voriconazole use.
Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Salvage Therapy; Transplantation, Homologous; Triazoles | 2007 |
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mycoses; Neutropenia; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles | 2007 |
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2007 |
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole | 2009 |
Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
Topics: Absidia; Aged; Antifungal Agents; Diabetes Complications; Foot Injuries; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mucormycosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Rare pulmonary mycoses in patients with hematologic diseases].
Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 1998 |
Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Hypokalemia; Leukemia, Myeloid, Acute; Triazoles | 1989 |